Anti Snoring Devices Market

The market for Anti Snoring Devices was estimated at $981 million in 2025; it is anticipated to increase to $1.59 billion by 2030, with projections indicating growth to around $2.59 billion by 2035.

Report ID:DS1801127

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Anti Snoring Devices

Customization Available

Anti Snoring Devices - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Anti Snoring Devices Market Outlook

Revenue, 2025

$981M

Forecast, 2035

$2.59B

CAGR, 2026 - 2035

10.2%

The Anti Snoring Devices industry revenue is expected to be around $981.2 million in 2026 and expected to showcase growth with 10.2% CAGR between 2026 and 2035. The growing importance of anti snoring devices for the treatment of snoring and mild obstructive sleep apnea is a notable trend within the broader respiratory care and sleep health industries. This growing trend is marked by the rising significance of these devices. This is due to the efforts of both health care providers and manufacturers to offer early intervention options for people with these conditions. The market for sleep apnoea treatment is expected to expand due to an increase in sleep disordered breathing diagnosis, greater awareness of the impact of snoring on sleep quality and cardiovascular risks and the patients preference for a non invasive treatment which can be used in homecare settings. The 2025 market for anti snoring devices was dominated by oral appliances. This year these generated $376.78 million in sales, reflecting theindustry'sbelief in the usefulness and ease of mandibular advancement appliances and other oral devices which address the blockage of the upper airways and boost airflow. Across age groups, men and women continue to drive growth in the user base for this sleep disorder treatment technology. This demonstrates the products relevance for both the promotion of wellness and preventive care.

Anti snoring devices, also known as Nasal devices,, known as nasal devices, encompass a variety of products including jaw repositioning oral appliances, nasal dilators to increase nasal airflow and positional therapy devices which discourage sleeping in a horizontal position. Additionally, new smart devices which incorporate sensors and mobile apps are being developed to track breathing and sleeping patterns. These smart devices help to monitor snoring. Design that prioritizes comfort, adjustable and adaptable fit and quiet operation are just a few of the features which major manufacturers include in their products. Machines are built to last and cleaning them is relatively straightforward. As a result nightly use is more likely. In addition to this, due to the simpler design, patients tend to be more adherent to therapy. This is compared to people who use CPAP machines which are more complex. This device is used in the management of patients who suffer from mild sleep apnea or who are habitual snorers. It is also used to aid patients who have undergone a sleep study and are awaiting further treatment or in conjunction with other treatments if these are not only tolerated. This device is used in home settings and also in sleep disorder clinics. The rising sales of anti snoring devices are attributed to growing consumer demand for products sold through online and direct to consumer channels. Furthermore, demand is boosted by the integration of smart technology into devices which offer data driven sleep coaching. The growing alliance between manufacturers of anti snoring devices, dentists and sleep specialists, is also fuelling demand by offering effective, patient centred solutions which have been clinically validated.

Anti Snoring Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Anti Snoring Devices Market Outlook

Market Key Insights

The anti snoring devices market is expected to expand from $981.2 million in 2025 to $2.59 billion by 2035. The sectors growth over the last four years has been 10.2%, a clear indication that Noise Cancellation, the improvement of cardiovascular health and the treatment of sleep apnea are experiencing a rising level of demand.
Leading companies in the CPAP machines market include ResMed, SomnoMed and ProSomnus Sleep Technologies, the two entities impacting the competitive landscape.
The anti snoring devices market is expected to expand in the US and UK with growth rates of 7.4% to 10.7% per annum between 2025 and 2030.
The countries of India, Brazil and South Africa are expected to grow at the fastest rate in the emerging market category with a growth rate between 9.8% and 12.8% per annum.
The shift to online marketing is predicted to add $144 million to the anti snoring devices industry growth by 2030.
The anti snoring devices market will experience a growth of $1.6 billion between 2025 and 2035. In the process, the manufacturers are targeting key sections of the market where they will have a larger share.
The anti snoring market is predicted to grow by 164% from 2025 to 2035, mainly due to the rise in the incidence of snoring conditions along with a global increase in the elderly population.

Anti Snoring Devices - Country Share Analysis

Opportunities in the Anti Snoring Devices

In Asias developing economies, anti snoring devices offered through e commerce and telemedicine sleep clinics are still largely unexplored. While smartphones and online sleep health tools let doctors remotely assess patients who are snoring, they can also recommend cheap products such as nasal strips to mild sufferers. By 2030, sales of nasal devices are forecast to increase from $226.66 million to $339.25 million. Chin straps are expected to reach $118.62 million in sales at that time, showing the products have strong potential for expansion. This nasally delivered opportunity will see growth of a cheap nasal delivery device at the fastest rate in its region.

Growth Opportunities in North America and Europe

The North American market for anti snoring devices is driven mainly by the awareness among people of sleep apnea and a desire from consumers to purchase high end products, in which males generated the highest revenue. The most promising region's of expansion lie in marketing Mandibular Advancement Devices and the CPAP alternative oral appliances as both medically approved and simple to use oral devices for male heavy snorers. Opportunities also exist in developing stop snoring products specifically tailored to the needs of women. As the sleep health industry continues to grow, companies are now differentiating themselves in several region's. Dental focused makers of custom dental appliances are competing with other established sleep health companies. Telehealth and e commerce models are being used by some companies to differentiate their products. These companies are competing based on comfort, how well they integrate with other health data, and the replacement cycle for their products. Key regional drivers in this region include a high prevalence of obesity, strong diagnosis rates, extensive health insurance coverage for sleep disorder treatment devices and a mature market in this field. This market is one that rewards products which have different features, such as products which operate quietly and are durable and also easy to adjust. This is particularly the case in products that are targeted at men with female versions of the products also available.

In Europe, growth in the anti snoring devices market is influenced by a number of factors. These include strict regulations and a strong primary healthcare sector. It is a culture which encourages preventative healthcare. The key demographic for this market is women, despite men having a higher incidence of the condition. Women in particular are likely to be drawn to quiet, discreet snoring solutions. These could include oral appliances which are low profile and designed with aesthetics in mind. The branding should encompass the importance of rest quality and the impact this has on womens partners and their own daily performance. European makers of mandibular advancement devices have to differentiate their products, particularly when selling them to local pharmacies or retailers. This is because the market is divided between national online sellers and companies. As a result manufacturers should consider using eco friendly materials, conforming to the very latest safety regulations or customising their devices as per the specific dental and jaw structure of the countries in question. Key factors which influence the market in this region include the demographics of an ageing population which is becoming increasingly health conscious. In addition, women are participating in wellness and preventive care programmes at a high rate, and digital pharmacies are becoming more accessible. Furthermore, doctors tend to use non invasive, over the counter treatments initially. These factors suggest that the market will benefit from products and marketing targeted at women.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Sleep Apnea and Increasing Awareness of Snoring Health Risks

The growing prevalence of obstructive sleep apnea (OSA) worldwide is also a significant factor driving the demand for anti-snoring devices. Increasing urbanization, sedentary lifestyles, obesity, and aging populations have also led to higher rates of sleep-disordered breathing, particularly among adults over 40. Patients are also increasingly seeking non-invasive, home-based solutions to manage their condition, driving adoption of mandibular advancement devices and CPAP-compatible snoring aids. Separately, awareness about the health risks associated with chronic snoring, such as daytime fatigue, cognitive impairment, and cardiovascular Devices complications, has also expanded the consumer base.

The rapid development of smart anti-snoring devices with features like vibration alerts, app connectivity, and real-time monitoring is also driving market growth. These innovations allow personalized adjustments based on sleeping patterns, increasing efficacy and comfort. Devices integrating noise cancellation and AI-enabled feedback are also gaining popularity among tech-savvy users. Key players like Smart Nora, ResMed, and SomnoMed are also leveraging these advancements to differentiate products, improve compliance, and expand the adoption of anti-snoring solutions across home and clinical settings.

Restraint: High Consumer Skepticism and Low Long‑Term Adherence Limit Market Growth

Many users experience discomfort or limited effectiveness with anti snoring devices such as mandibular advancement devices or electronic vibration units, leading to poor long‑term adherence. Consumer skepticism about benefits can slow adoption, especially when initial trial results vary. For example, some users abandon devices due to jaw soreness or inconsistent snoring reduction, reducing repeat purchases and dampening overall market revenue and demand for premium, clinically backed solutions.

Opportunity: Rising demand for Anti Snoring Devices among overweight middle-aged men in North American home settings and Growing adoption of smart positional Anti Snoring Devices for CPAP-intolerant mild sleep apnea patients globally

A considerable number of anti snoring devices are sold in North America to the overweight middle aged male market which remains an untapped opportunity for home healthcare products. As a result of bulky nature of sleep apnea machines many consumers refuse to use them, causing a demand for oral appliances or nasal devices which have been clinically proven to be effective. The global oral appliance industry is currently valued at $376.78 million. It is estimated that this figure will reach $640.64 million by the year 2030. This significant projected growth is a testament to the scope of the market. The growth of the market is to be assisted by the coupling of oral appliances with employer wellness programs and home sleep monitoring systems. These programmes are directed at specific demographic groups.

On a worldwide basis, anti snoring smart positional devices have high growth potential as a substitute for CPAP intolerant mild apnea sufferers. Pulse oximeters integrated with position control devices which are linked with sleep trackers enable their users to keep track of their position while asleep, thus providing them with more targeted feedback and improving the efficacy of their treatment. By the year 2030, global position control devices are expected to expand from 165.8 million dollars to 301.48 million dollars. This growth will represent the highest compound annual growth rate, at 12.7% , of any anti snoring devices product. Positioning technology will drive this opportunity, which should make position control devices grow in value faster than other devices, including nasal devices.

Challenge: Limited Insurance Coverage and Cost Barriers Restrict Broader Adoption

Anti snoring devices are often treated as out‑of‑pocket purchases rather than reimbursable medical equipment, which limits demand among price‑sensitive consumers. Higher‑end devices with advanced features such as smart noise cancellation or sleep apnea compatibility can be costly, discouraging uptake. For instance, individuals may opt for cheaper OTC aids or lifestyle changes instead of investing in premium devices, reducing sales growth and slowing penetration in key markets such as North America and Europe.

Supply Chain Landscape

Anti Snoring Devices R&D

ResMedProSomnus Sleep Technologies

Mandibular Device Manufacturing

SomnoMedDynaFlex

Sleep Apnea Therapy Distribution

Vivos TherapeuticsResMed

Snoring Treatment End Users

Sleep clinicsHome healthcareOnline retail

Anti Snoring Devices R&D

ResMedProSomnus Sleep Technologies

Mandibular Device Manufacturing

SomnoMedDynaFlex

Sleep Apnea Therapy Distribution

Vivos TherapeuticsResMed

Snoring Treatment End Users

Sleep clinicsHome healthcareOnline retail

Anti Snoring Devices - Supply Chain

Use Cases of Anti Snoring Devices in Sleep Apnea Treatment & Noise Cancellation

Sleep Apnea Treatment : Mandibular advancement devices are widely used for sleep apnea treatment, helping keep the airway open during sleep. These devices are commonly prescribed by sleep specialists and ENT clinics for patients with mild to moderate obstructive sleep apnea. They reduce snoring intensity while improving oxygen saturation and sleep quality. Leading players like ResMed, SomnoMed, and ProSomnus offer clinically validated devices known for comfort, durability, and high patient adherence, positioning them as market leaders in the sleep apnea management segment.

Noise Cancellation : Electronic anti-snoring devices with built-in noise cancellation are popular for reducing disruptive snoring sounds in shared sleeping environments. Typically used by individuals in home settings or travel scenarios, these devices combine sound masking technology with gentle vibration alerts to improve partner sleep quality. Key companies such as Smart Nora, Good Morning Snore Solution, and SnoreRx focus on user-friendly designs, reliability, and quiet operation, giving them a strong market position in personal snoring management solutions.

Improving Cardiovascular Health : Mandibular advancement devices and CPAP-compatible anti-snoring solutions are increasingly recommended to improve cardiovascular health in patients with obstructive sleep apnea. By reducing nocturnal hypoxia and controlling airway obstruction, these devices lower the risk of hypertension, arrhythmias, and heart disease. Leading players like ResMed, Philips Respironics, and SomnoMed provide clinically proven, comfortable, and easy-to-use devices, helping healthcare providers enhance patient outcomes while establishing their dominance in cardiovascular risk management through effective sleep apnea treatment.

Recent Developments

The Nasal devices market has advanced with innovations in smart sleep technology, including sensor-enabled mandibular advancement devices and app-integrated nasal dilators that monitor snoring patterns in real time. Recent developments focus on improving patient compliance, comfort, and efficacy, with companies like ResMed, Philips Respironics, and SomnoMed leading the space. A key market trend is the growing adoption of non-invasive, user-friendly oral appliances for home-based sleep apnea treatment, driving demand in dental sleep medicine, home healthcare, and consumer wellness segments globally.

January 2025 : ResMed completed the acquisition of Somnowell, a UK‑based provider of custom oral appliances for snoring and sleep apnea, expanding its portfolio of anti‑snoring and sleep apnea solutions and strengthening its position in the global sleep health market.

April 2025 : Vivos Therapeutics signed a distribution agreement with Henry Schein to broaden access to its anti‑snoring oral appliances across healthcare providers, enhancing market reach and adoption.

Impact of Industry Transitions on the Anti Snoring Devices Market

As a core segment of the Medical Device industry, the Anti Snoring Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift Towards Online Marketing and Shift Toward Non-Invasive, User-Friendly Designs have redefined priorities across the Medical Device sector, influencing how the Anti Snoring Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Shift Towards Online Marketing

The growing online marketing trend is also seen as a driving force behind the expansion of the anti snoring devices market, with online sales resulting in an estimated increase in market size of $144 million by the year 2030. With more consumers of all ages turning to the internet to research and buy remedies for their snoring, anti snoring product manufacturers are now using a variety of digital marketing techniques to tailor their sales and marketing strategies. With a digital sales platform, we are able to divide offerings into specific product groups such as oral appliances or sleep apnea aids, thereby offering CPAP machine alternatives. This increases sales while relying less on stores. Companies that build up online marketing techniques early on and offer a range of shopping experiences will be in the best position to increase sales, increase their customer base and increase customer satisfaction.

Shift Toward Non-Invasive, User-Friendly Designs

Anti snoring devices such as nasal dilators and mouthpieces are gaining popularity as they are discreet and can be easily used by anyone. These devices comprise of mandibular advancement devices and soft oral appliances. People who use these designs are likely to adhere to treatment since the appliances are designed to be comfortable, lightweight and minimally invasive, thereby reducing disruption to the users sleep patterns. Major players in the market such as Philips Respironics, the Good Morning Snore Solution and SnoreRx have launched the ergonomic and patient friendly anti snoring devices. Theindustry'sshift in the diagnosis and treatment of sleep disorders has repercussions on associated fields such as dental sleep medicine and sleep medicine, especially those connected to healthcare.